Literature DB >> 10084611

The human prolactin receptor gene structure and alternative promoter utilization: the generic promoter hPIII and a novel human promoter hP(N).

Z Z Hu1, L Zhuang, J Meng, M Leondires, M L Dufau.   

Abstract

The 5'-untranslated region of the human prolactin receptor (hPRLR) gene contains two alternative first exons, hE1(3), the human counterpart of the rat and mouse E1(3) and a novel human type of alternative first exon termed hE1N, also a common non-coding exon 2 and a third exon containing the translation initiation codon. hE1(3) was localized approximately 800 bp 5' from the hE1N in the genome. The two distinct first exons hE1(3) and hE1N are expressed in human breast tissue, breast cancer cells, gonads and liver. Overall, the transcript containing hE1(3) is prevalent in most tissues. The coding region of the gene comprises eight exons (exon 3-10), in which exon 10 encodes most of the intracellular domain. hE1(3) and hE1N are transcribed from alternative promoters hPIII and hP(N), respectively. The hPIII, containing identical Sp1 and C/EBP elements as in the rodent promoters, shares 81% similarity in the region -480/-106 to both the rat and mouse. The novel promoter hP(N) contains putative binding sites for ETS-family proteins and a half-site for nuclear receptors. Therefore, both promoters likely utilize distinct mechanisms in controlling the hPRLR gene transcription. The different promoter utilization of the hPRLR gene in diverse tissues may confer differential prolactin response through activation of different promoters.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10084611     DOI: 10.1210/jcem.84.3.5659

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Complex formation and interactions between transcription factors essential for human prolactin receptor gene transcription.

Authors:  Jung-Hoon Kang; Chon-Hwa Tsai-Morris; Maria L Dufau
Journal:  Mol Cell Biol       Date:  2011-06-13       Impact factor: 4.272

Review 2.  New insights in prolactin: pathological implications.

Authors:  Valérie Bernard; Jacques Young; Philippe Chanson; Nadine Binart
Journal:  Nat Rev Endocrinol       Date:  2015-03-17       Impact factor: 43.330

3.  Progesterone induces expression of the prolactin receptor gene through cooperative action of Sp1 and C/EBP.

Authors:  Anita S Goldhar; Renqin Duan; Erika Ginsburg; Barbara K Vonderhaar
Journal:  Mol Cell Endocrinol       Date:  2011-01-14       Impact factor: 4.102

Review 4.  Regulation of prolactin receptor levels and activity in breast cancer.

Authors:  G Swaminathan; B Varghese; S Y Fuchs
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-19       Impact factor: 2.673

5.  Intramolecular disulfide bonds of the prolactin receptor short form are required for its inhibitory action on the function of the long form of the receptor.

Authors:  Y-L Xie; S A Hassan; A M Qazi; C H Tsai-Morris; M L Dufau
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

6.  Impact of subdomain D1 of the short form S1b of the human prolactin receptor on its inhibitory action on the function of the long form of the receptor induced by prolactin.

Authors:  J-H Kang; S A Hassan; P Zhao; C H Tsai-Morris; M L Dufau
Journal:  Biochim Biophys Acta       Date:  2014-04-13

7.  Essential role of endogenous prolactin and CDK7 in estrogen-induced upregulation of the prolactin receptor in breast cancer cells.

Authors:  Raghuveer Kavarthapu; Maria L Dufau
Journal:  Oncotarget       Date:  2017-04-18

8.  A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.

Authors:  Sulggi A Lee; Christopher A Haiman; Noel P Burtt; Loreall C Pooler; Iona Cheng; Laurence N Kolonel; Malcolm C Pike; David Altshuler; Joel N Hirschhorn; Brian E Henderson; Daniel O Stram
Journal:  BMC Med Genet       Date:  2007-12-01       Impact factor: 2.103

9.  Systematic analysis of alternative first exons in plant genomes.

Authors:  Wei-Hua Chen; Guanting Lv; Congying Lv; Changqing Zeng; Songnian Hu
Journal:  BMC Plant Biol       Date:  2007-10-17       Impact factor: 4.215

10.  Role of EGF/ERBB1 in the transcriptional regulation of the prolactin receptor independent of estrogen and prolactin in breast cancer cells.

Authors:  Raghuveer Kavarthapu; Maria L Dufau
Journal:  Oncotarget       Date:  2016-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.